FuturHealth Price: GLP-1 Costs & Clinical Value

Last reviewed: May 16, 2026

Last updated: May 16, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

FuturHealth pricing structures typically range from $99 to $300+ monthly depending on medication type and program tier. Understanding what drives these costs—from medication compound selection to provider oversight fees—is essential for comparing value across telemedicine GLP-1 programs.

Price alone doesn't determine treatment success. Factors like individual peptide receptor genetics, baseline metabolic markers, and medication tolerability significantly influence outcomes. PlexusDx emphasizes precision wellness by combining transparent pricing with optional genetic context to support more personalized provider conversations.

How GLP-1 Program Costs Break Down

GLP-1 program pricing typically includes three components: the medication itself (semaglutide or tirzepatide), clinical consultation and monitoring fees, and pharmacy dispensing costs. Different programs bundle these differently, which creates apparent price variation even when base medication costs are similar.

Compounded GLP-1 medications from licensed 503A pharmacies generally cost less than branded equivalents because they avoid brand markup and marketing expenses. However, program overhead—provider licensing, telehealth platform infrastructure, and ongoing clinical support—varies significantly between platforms, affecting total monthly fees.

GLP-1 Pricing Models: Telehealth vs. Traditional Programs

Telemedicine GLP-1 programs like FuturHealth typically streamline costs by reducing in-person visits and office overhead. However, this model requires robust provider oversight, pharmacy licensing verification, and dosing protocol standardization to ensure safety and efficacy. Different platforms prioritize these elements differently, affecting pricing.

Program Type	Typical Monthly Cost	Key Cost Drivers
Telemedicine GLP-1 (Compounded)	$129-$369/mo	Medication compound, provider oversight, monitoring frequency
Branded Ozempic/Wegovy (with insurance)	$0–$150 copay	Insurance coverage; list price ~$900/month without coverage
Traditional Weight Loss Clinics	$200–$500+	In-person visits, advanced lab work, specialized providers
Microdose GLP-1 Protocols	$129–$180	Lower doses, longer supply duration, simplified monitoring

Medication Selection and Its Impact on Price

Semaglutide and tirzepatide—the two primary GLP-1 receptor agonists—differ in mechanism, dosing schedules, and efficacy. Tirzepatide activates both GLP-1 and GIP receptors, potentially offering greater glucose control and weight loss. This dual action sometimes justifies higher pricing despite similar manufacturing costs.

Oral formulations typically cost more than injections because oral bioavailability requires specialized manufacturing and larger doses to achieve comparable blood concentrations. Dual-compound protocols like GLP-Squared combine two agonists at lower individual doses, which may suit patients with specific tolerability or efficacy profiles.

Genetic Predisposition and Treatment Economics

Individual variation in GLP-1 receptor and GIP receptor genetics may influence medication tolerability, dosing requirements, and weight loss magnitude. Understanding these predispositions doesn't predict exact outcomes but may provide context for why one medication or protocol suits a patient better than another, potentially affecting long-term cost-effectiveness.

The Precision Peptide Genetic Test examines variants in GLP1R, GIPR, FTO, and MC4R—genes influencing peptide pathway function. While genetics represent only one factor in treatment response, this context can support more informed medication selection with a provider, potentially reducing trial-and-error and associated costs.

Hidden Costs and Total Cost of Care Considerations

Beyond medication price, GLP-1 treatment costs include initial assessment fees, lab work (baseline lipids, glucose, liver/kidney function), and follow-up monitoring visits. Some programs bundle these; others charge separately. Clarifying what's included prevents surprise costs and helps with budgeting.

Compounded medications from licensed 503A pharmacies offer consistency and transparency, but patients should verify their pharmacy's state licensing, compounding verification, and quality standards. Long-term adherence costs also depend on sustained provider support and dosing adjustments based on clinical response.

How PlexusDx Supports a More Personalized Approach

PlexusDx compounded GLP-1 options range from $129/month (microdose protocol) to $325/month (GLP-Squared dual compound), all from licensed 503A pharmacies. Transparent pricing reflects actual medication costs plus professional oversight—no hidden enrollment or monitoring fees. This directness helps patients compare value against other platforms clearly.

The Precision Peptide Genetic Test ($99 add-on or $298 standalone) examines predispositions in GLP1R, GIPR, FTO, and MC4R pathways. These variants may help provide context for individual responsiveness to GLP-1 therapy, but genetics alone do not predict exact medication response or weight loss magnitude. Results should be interpreted with a qualified healthcare provider.

Pairing transparent PlexusDx pricing with optional genetic insights creates a framework for more informed provider conversations. Rather than guessing which medication or dose suits a patient, providers can consider both biomarker context and cost structure when selecting a treatment path aligned with individual health goals and budget constraints.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Microdose Glp1 Protocol starts at $129/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is FuturHealth's typical monthly medication cost compared to PlexusDx?

FuturHealth pricing varies by program tier; compounded options typically range $150–$300/month. PlexusDx compounded semaglutide starts at $179/month, tirzepatide at $229/month, with microdose protocols at $129/month. All use licensed 503A pharmacies with transparent pricing.

Why does tirzepatide cost more than semaglutide?

Tirzepatide activates dual GLP-1 and GIP receptors, offering potential advantages in glucose control and weight loss compared to single-agonist semaglutide. Higher efficacy, more complex manufacturing, and increased demand typically drive higher pricing.

Are hidden fees involved with PlexusDx compounded GLP-1?

PlexusDx pricing is transparent: medication cost plus provider oversight. No separate enrollment, monitoring, or lab processing fees. Patients should clarify whether initial assessment labs and follow-up visits are included in their provider's consultation structure.

Can genetic testing help predict which GLP-1 medication will work best?

The Precision Peptide Genetic Test reveals predispositions in peptide receptor pathways but does not predict exact medication response. Genetics represent one factor among many. Results should inform provider conversations about medication selection, not replace clinical judgment or medical evaluation.

Is compounded GLP-1 from PlexusDx as safe as branded Ozempic or Wegovy?

PlexusDx compounded medications come from licensed 503A pharmacies meeting state and federal standards. Compounded semaglutide and tirzepatide are not FDA-approved (branded drugs are), but 503A compounds follow strict quality and sterility protocols under pharmacist supervision. Safety depends on proper medical oversight.

FuturHealth Price: Comparing GLP-1 Treatment Costs and Clinical Value